Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources

SIMPLE SUMMARY: Using Italian national data from more than 8000 patients, we proposed a novel model calculating the net benefit of liver transplantation (individual benefit minus harm to others on the waiting list) in T2 hepatocellular carcinoma (HCC) patients in different scenarios of transplant ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Cillo, Umberto, Vitale, Alessandro, Volk, Michael L., Frigo, Anna Chiara, Feltracco, Paolo, Cattelan, Annamaria, Brancaccio, Giuseppina, Feltrin, Giuseppe, Angeli, Paolo, Burra, Patrizia, Lonardi, Sara, Trapani, Silvia, Cardillo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003429/
https://www.ncbi.nlm.nih.gov/pubmed/33808790
http://dx.doi.org/10.3390/cancers13061416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003429/
https://www.ncbi.nlm.nih.gov/pubmed/33808790
http://dx.doi.org/10.3390/cancers13061416

Ejemplares similares